ATL13 (AT4G30400) is a member of the Arabidopsis Tóxicos en Levadura (ATL) family of RING-H2 type E3 ubiquitin ligases. It belongs to a plant-specific family of proteins named after the toxic phenotype exhibited by ATL2 (the first identified member) when conditionally expressed in Saccharomyces cerevisiae. The protein contains a RING-H2 finger domain, which is one of the two major types of RING domains found in Arabidopsis thaliana, the other being RING-HC . The RING-H2 domain is characterized by specific spacing between zinc ligands and the substitution of histidine for cysteine at specific positions in the zinc coordination pattern.
ATL13 functions as a RING-type E3 ubiquitin transferase in the ubiquitin-proteasome system. The RING-H2 finger domain mediates the interaction with E2 ubiquitin-conjugating enzymes, facilitating the transfer of ubiquitin to target proteins. This process marks these targets for degradation by the 26S proteasome. The specificity of substrate recognition is determined by regions outside the RING domain . ATL family proteins, including ATL13, are believed to play roles in various plant physiological processes through the regulated degradation of specific protein targets, although the specific substrates of ATL13 have not been fully characterized in the current literature.
Based on available data, E. coli has been successfully used to express recombinant ATL13. Specifically, a full-length recombinant version (1-472aa) with an N-terminal His tag has been effectively produced in E. coli systems . This suggests that bacterial expression is suitable for obtaining functional protein for in vitro studies. When designing expression constructs, researchers should consider:
Codon optimization for E. coli expression
Selection of appropriate fusion tags (His tag has been demonstrated to work effectively)
Optimization of induction conditions to maximize soluble protein yield
Consideration of protein toxicity issues that might affect expression levels
Recombinant ATL13 protein stability is maximized under the following conditions:
| Storage Parameter | Recommendation | Notes |
|---|---|---|
| Long-term storage | -20°C to -80°C | Aliquoting is necessary to prevent freeze-thaw damage |
| Working storage | 4°C | Suitable for up to one week |
| Storage buffer | Tris/PBS-based buffer with 6% Trehalose, pH 8.0 | Helps maintain protein stability |
| Reconstitution | Deionized sterile water (0.1-1.0 mg/mL) with 5-50% glycerol | 50% final glycerol concentration is commonly used |
It is strongly advised to avoid repeated freeze-thaw cycles as they significantly compromise protein integrity and activity . Proper aliquoting upon initial reconstitution is critical for maintaining consistent results in downstream applications.
For optimal reconstitution of lyophilized recombinant ATL13:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (with 50% being commonly used)
Prepare multiple small-volume aliquots to avoid repeated freeze-thaw cycles
Store reconstituted aliquots at -20°C/-80°C for long-term storage or at 4°C for up to one week for active use
This protocol helps maintain the structural integrity and functional activity of the protein for subsequent experimental applications.
For in vitro ubiquitination assays using recombinant ATL13, researchers should consider the following methodological approach:
Components required:
Purified recombinant ATL13 (RING-H2 E3 ligase)
E1 ubiquitin-activating enzyme
Appropriate E2 ubiquitin-conjugating enzyme (testing multiple E2s is advisable)
Ubiquitin (consider using tagged versions for easier detection)
ATP and ATP regeneration system
Putative substrate proteins (if known)
Reaction conditions:
Buffer: Typically Tris-based (pH 7.5-8.0) with MgCl₂ and DTT
Temperature: 30-37°C
Duration: 1-2 hours or time course analysis
Controls to include:
Negative control: Reaction without E3 ligase (ATL13)
Negative control: Reaction without ATP
Positive control: Well-characterized E3-substrate pair
Detection methods:
Western blotting using anti-ubiquitin antibodies
If using tagged ubiquitin: detection via the tag (e.g., anti-His for His-tagged ubiquitin)
Using both anti-substrate and anti-ubiquitin antibodies to confirm ubiquitination
The key challenge in these assays is identifying the physiological substrates of ATL13, which may require additional approaches such as yeast two-hybrid screening or co-immunoprecipitation experiments to identify interacting proteins.
To investigate ATL13 function in Arabidopsis thaliana:
Genetic approaches:
T-DNA insertion mutants analysis
CRISPR/Cas9-mediated gene editing
RNAi-mediated knockdown
Overexpression lines using the native promoter or constitutive promoters
Protein localization studies:
GFP/YFP fusion proteins to determine subcellular localization
Immunolocalization using specific antibodies against ATL13
Physiological and biochemical assays:
Phenotypic analysis under various stress conditions
Protein stability assays with and without proteasome inhibitors
Comparative proteomics between wild-type and atl13 mutants to identify accumulated proteins (potential substrates)
Interaction studies:
Co-immunoprecipitation to identify interacting proteins
Bimolecular fluorescence complementation (BiFC) to confirm interactions in planta
Yeast two-hybrid screening to identify potential substrates and regulatory proteins
When designing these experiments, it's important to consider the potential functional redundancy with other ATL family members, which might necessitate the creation of multiple mutant lines.
The RING-H2 domain of ATL13 shares the characteristic features of ATL family proteins but also has distinctive elements:
Conserved features across ATL family:
Distinguishing features of ATL13:
UniProt ID: Q940Q4
Specific residues in the RING domain that may influence E2 enzyme selection
Additional domains that work in conjunction with the RING-H2 domain
Evolutionary considerations:
Understanding these structural distinctions is crucial for predicting functional differences between ATL family members and for designing specific inhibitors or interactors.
Researchers frequently encounter several challenges when working with recombinant ATL13:
To confirm that purified recombinant ATL13 retains its E3 ligase activity:
Auto-ubiquitination assay:
Many RING E3 ligases can undergo auto-ubiquitination in vitro
This provides a straightforward functional assay even without known substrates
Reaction components: ATL13, E1, E2, ubiquitin, ATP
Detection via Western blot showing higher molecular weight species of ATL13
Structural integrity verification:
Circular dichroism (CD) spectroscopy to assess secondary structure
Thermal shift assays to evaluate protein stability
Zinc content analysis to confirm proper metal coordination
E2 binding assays:
Pull-down assays with different E2 enzymes
Surface plasmon resonance (SPR) to measure binding kinetics
Isothermal titration calorimetry (ITC) for thermodynamic binding parameters
These approaches provide complementary information about the structural integrity and functional capacity of the recombinant protein.
Several analytical techniques are particularly valuable for characterizing interactions between ATL13 and its partners:
For E2-E3 interactions:
Yeast two-hybrid (Y2H) screening with various E2 enzymes
Pull-down assays using tagged recombinant proteins
SPR or bio-layer interferometry (BLI) for real-time interaction kinetics
NMR spectroscopy for structural details of the interaction interface
For substrate identification and characterization:
Protein microarrays to screen for ubiquitination targets
Tandem affinity purification coupled with mass spectrometry (TAP-MS)
Quantitative proteomics comparing wild-type and atl13 mutant plants
Proximity-dependent biotin identification (BioID) in planta
For validating and characterizing specific interactions:
Mutagenesis of key residues to disrupt specific interactions
Co-crystal structure determination of ATL13 with partners
In vitro competition assays to assess binding specificity
Cellular co-localization studies to confirm physiological relevance
Comparative studies between ATL13 and other ATL family members represent an important research direction:
Phylogenetic analysis:
Comprehensive phylogenetic analysis of ATL13 in relation to other ATL proteins can reveal evolutionary relationships
The central region of the RING-H2 domain is particularly informative for classification
Identification of ATL13 orthologs across plant species can provide insights into conservation and functional importance
Domain swapping experiments:
Exchanging domains between ATL13 and other ATL proteins to determine regions responsible for functional specificity
Creating chimeric proteins to test substrate specificity determinants
Systematically mutating residues that differ between ATL family members
Expression and localization patterns:
Comparative analysis of expression patterns under various conditions
Comparison of subcellular localization to identify potential functional divergence
Co-expression analysis to identify functional networks
Substrate specificity:
Comparing the substrate profiles of different ATL proteins
Determining the structural basis for substrate recognition differences
Investigating potential overlapping functions and redundancy
These comparative approaches could reveal how ATL13 has evolved specialized functions within the broader ATL family context.
Identifying the physiological substrates of ATL13 is a critical step in understanding its function:
Global proteomics approaches:
Quantitative proteomics comparing wild-type and atl13 mutant plants
Ubiquitinome analysis to identify differentially ubiquitinated proteins
Protein stability profiling to identify proteins with altered half-lives
Targeted interaction screens:
Yeast two-hybrid screens using ATL13 as bait
Protein microarrays to identify direct ubiquitination targets
Proximity-dependent labeling (BioID or TurboID) in plant cells
Candidate-based approaches:
Testing proteins involved in pathways where ATL13 has been implicated
Investigating proteins that co-localize with ATL13
Examining proteins with expression patterns that inversely correlate with ATL13
Validation strategies:
In vitro ubiquitination assays with candidate substrates
Co-immunoprecipitation to confirm interactions
Genetic interaction studies (e.g., epistasis analysis)
Analysis of candidate substrate levels in response to ATL13 overexpression or knockout
The combination of these approaches will likely be necessary to comprehensively identify and validate ATL13 substrates.
To effectively investigate ATL13 function in specific plant processes, researchers should consider a multi-layered experimental approach:
Phenotypic characterization:
Generate and characterize atl13 knockout/knockdown lines
Create ATL13 overexpression lines
Analyze phenotypes under various conditions (developmental stages, stress treatments)
Look for subtle phenotypes that might be masked by redundancy
Expression analysis:
Determine spatiotemporal expression patterns using promoter-reporter constructs
Analyze expression changes in response to various stimuli
Compare with expression patterns of other ATL family members
Functional genomics:
RNA-seq analysis of atl13 mutants to identify affected pathways
ChIP-seq to identify potential transcriptional effects
Metabolomics to detect changes in metabolite profiles
Protein function studies:
Create versions with mutations in key domains (RING domain, transmembrane domain)
Assess protein-protein interactions in planta
Determine the subcellular localization under various conditions
This comprehensive approach maximizes the likelihood of uncovering the specific biological processes in which ATL13 participates, even in the presence of potential functional redundancy with other E3 ligases.
For structural studies of recombinant ATL13, researchers should consider:
Protein preparation considerations:
Expression of individual domains versus full-length protein
Selection of appropriate tags and cleavage sites
Protein homogeneity requirements (size-exclusion chromatography)
Buffer optimization to prevent aggregation and promote stability
Structural technique selection:
X-ray crystallography: Requires high concentration and crystallization conditions
NMR spectroscopy: Suitable for individual domains, requires isotope labeling
Cryo-EM: Potentially useful for complexes with E2 enzymes or substrates
Small-angle X-ray scattering (SAXS): For low-resolution envelope information
Potential complexes to study:
ATL13 RING domain with E2 enzymes
ATL13 in complex with substrate proteins
ATL13 transmembrane domain in membrane mimetics
Functional validation:
Correlating structural features with biochemical activity
Structure-guided mutagenesis to validate functional hypotheses
Comparing structural features with other ATL family members
Careful consideration of these factors will enhance the likelihood of success in structural studies and provide valuable insights into ATL13 function.